These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 1718462)
1. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example. Vol'pina OM; Surovoi AYu ; Ivanov VT Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462 [TBL] [Abstract][Full Text] [Related]
2. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology. Brown F Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918 [No Abstract] [Full Text] [Related]
3. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22]. Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673 [TBL] [Abstract][Full Text] [Related]
4. [Protection from foot-and-mouth disease virus in naturally-susceptible animals by a linear polymer of a synthetic peptide]. Pavlov AV; Rybakov SS; Ivaniushchenkov VN; Chepurkin AV; Petrov VN; Driagalin NN; Burdov AN Bioorg Khim; 1991 Jul; 17(7):953-63. PubMed ID: 1665331 [TBL] [Abstract][Full Text] [Related]
5. Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1. Doel TR; Gale C; Brooke G; DiMarchi R J Gen Virol; 1988 Sep; 69 ( Pt 9)():2403-6. PubMed ID: 2457649 [TBL] [Abstract][Full Text] [Related]
6. [Synthesis and immunogenic properties of peptides--fragments of the immunodominant regions of the VP1 protein of the Asia-1 type of foot- and-mouth disease virus]. Petrov VN; Rybakov SS; Petrova ON; Chepurkin AV; Gulenkin VM Bioorg Khim; 1998 Dec; 24(12):899-905. PubMed ID: 10079947 [TBL] [Abstract][Full Text] [Related]
7. [Chemosynthetic peptides against foot-and-mouth disease--immune response to free and carrier bound peptides of the VP1 of O1-Kaufbeuren]. Liebermann H; Reimann I; Bartels T; Nöckler A; Thalmann G; Furkert J; Dölling R Arch Exp Veterinarmed; 1990; 44(2):189-97. PubMed ID: 1696803 [TBL] [Abstract][Full Text] [Related]
8. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72. Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734 [TBL] [Abstract][Full Text] [Related]
9. [Antigenic structure of the foot-and-mouth virus. V. Protection of naturally susceptible animals from foot-and-mouth disease using a synthetic peptide]. Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Driagalin NN; Ivaniushchenkov VM Bioorg Khim; 1989 Oct; 15(10):1313-7. PubMed ID: 2561049 [TBL] [Abstract][Full Text] [Related]
10. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren. Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360 [TBL] [Abstract][Full Text] [Related]
11. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos. Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548 [TBL] [Abstract][Full Text] [Related]
12. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612 [TBL] [Abstract][Full Text] [Related]
13. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice. Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431 [TBL] [Abstract][Full Text] [Related]
17. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Mayr GA; Chinsangaram J; Grubman MJ Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121 [TBL] [Abstract][Full Text] [Related]
18. New approaches to vaccination against foot-and-mouth disease. Brown F Vaccine; 1992; 10(14):1022-6. PubMed ID: 1335197 [TBL] [Abstract][Full Text] [Related]
19. High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease. Steward MW; Stanley CM; Dimarchi R; Mulcahy G; Doel TR Immunology; 1991 Jan; 72(1):99-103. PubMed ID: 1847695 [TBL] [Abstract][Full Text] [Related]
20. Synthetic peptides as potential vaccines against foot-and-mouth disease. Brown F Endeavour; 1990; 14(2):87-94. PubMed ID: 1697533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]